Skip to main navigation Skip to search Skip to main content

Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: Morphologic features and pharmacokinetic and pharmacodynamic mechanisms

  • J. E. Low
  • , A. L. Metz
  • , T. E. Mertz
  • , S. P. Henry
  • , P. Knowlton
  • , G. Loewen
  • , C. S. Sommers
  • , D. G. Robertson
  • , B. J. Olszewski
  • , R. L. Schroeder
  • , A. W. Gough
  • , J. Keiser
  • , D. Mann
  • Pfizer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)930-939
Number of pages10
JournalJournal of Cardiovascular Pharmacology
Volume25
Issue number6
DOIs
StatePublished - Jan 1995
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Keywords

  • Cardiac hypertrophy
  • Catecholamine
  • Rats
  • β- Adrenoceptor

Fingerprint

Dive into the research topics of 'Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: Morphologic features and pharmacokinetic and pharmacodynamic mechanisms'. Together they form a unique fingerprint.

Cite this